Tirzepatide

CAS NO:2023788-19-2

Tirzepatide is the first drug in a class of agents known as dual GLP-1 and GIP receptor agonists.Tirzepatide is FDA-approved for weight loss in adults with obesity or who are overweight and have weight-related medical problems.

  • Appearance: White Powder of Crystalline
  • Purity: 99%
  • Capacity: 700KG Per Year
  • Process: Fully Chemical Synthesis
  • Mol. F. :C₂₂₅H₃₄₈N₄₈O₆₈
  • Mol. Wt.: 4813.50 g/mol
  • Documents: DMF + FDA EIR
Make A Quick Enquiry

Related products

GLP-1 API

Semaglutide

CAS NO:910463-68-2

Semaglutide is an anti-diabetic medication used to treat type 2 diabetes and manage chronic weight.

Show More
GLP-1 API

Tirzepatide

CAS NO:2023788-19-2

Tirzepatide is the first drug in a class of agents known as dual GLP-1 and GIP receptor agonists.

show More
GLP-1 API

Liraglutide

CAS NO:204656-20-2

Liraglutide is used for weight loss, or improve blood sugar control or reduce cardiovascular risk.

show More

CDMO services

CDMO service is one of strengths of GenoHope. GenoHope can provide one-stop CDMO service from R&D to commercial production, especially for advanced intermediates and new compounds with “special high quality ” and “cost saving” requirements.

show More